CD8 TCR β chain repertoire expansions and deletions are related with immunologic markers in HIV-1-infected patients during treatment interruption

Journal of Clinical Virology

Volumn 58, Issue 4, 2013, Pages 703-709

  González Serna, Alejandro ^a   Abad Fernández, María ^b   Soriano Sarabia, Natalia ^c   Leal, Manuel ^a   Vallejo, Alejandro ^b  

^a HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^b HOSPITAL RAMÓN Y CAJAL   (Spain)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral treatment interruption; CD8 TCR repertoire; Effector memory cells; Immune activation; T cell exhaustion

Indexed keywords

T LYMPHOCYTE RECEPTOR BETA CHAIN;

ADULT; ARTICLE; CD8+ T LYMPHOCYTE; CELL ACTIVATION; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOPHENOTYPING; MAJOR CLINICAL STUDY; MALE; MEMORY CELL; MULTIGENE FAMILY; PRIORITY JOURNAL;

ANTIRETROVIRAL TREATMENT INTERRUPTION; CD8 TCR Β REPERTOIRE; EFFECTOR MEMORY CELLS; IMMUNE ACTIVATION; T CELL EXHAUSTION;

ADULT; ANALYSIS OF VARIANCE; ANTI-RETROVIRAL AGENTS; CD8-POSITIVE T-LYMPHOCYTES; COHORT STUDIES; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNOPHENOTYPING; MALE; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; YOUNG ADULT;

EID: 84888818872     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.017     Document Type: Article

References (42)

1. Mellors J.W., Margolick J.B., Phair J.P., Rinaldo C.R., Detels R., Jacobson L.P., et al. Prognostic value of HIV-1 RNA, CD4 cell count, and CD4 cell count slope for progression to AIDS and death in untreated HIV-1 infection. J Am Med Assoc 2007, 297:2349-2350.
2. Wherry E.J., Ha S.J., Kaech S.M., Haining W.N., Sarkar S., Kalia V., et al. Molecular signature of CD8 T-cell exhaustion during chronic viral infection. Immunity 2007, 27:670-684.
3. Haining W.N., Ebert B.L., Subrmanian A., Wherry E.J., Eichbaum Q., Evans J.W., et al. Identification of an evolutionarily conserved transcriptional signature of CD8 memory differentiation that is shared by T and B cells. J Immunol 2008, 181:1859-1868.
4. Day C.L., Kaufmann D.E., Kiepiela P., Brown J.A., Moodley E.S., Reddy S., et al. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 2006, 443:350-354.
5. Miconnet I., Marrau A., Farina A., Taffe P., Vigano S., Harari A., et al. Large TCR diversity of virus-specific CD8 T cells provides the mechanistic basis for massive TCR renewal after antigen exposure. J Immunol 2011, 186:7039-7049.
6. Garcia K.C., Teyton L., Wilson I.A. Structural basis of T cell recognition. Annu Rev Immunol 1999, 17:369-397.
7. Borrow P., Lewicki H., Hahn B.H., Shaw G.M., Oldstone M.B. Virus-specific CD8 cytotoxic T-lymphocyte activity associated with control of viremia in primary human immunodeficiency virus type 1 infection. J Virol 1994, 68:6103-6110.
8. Rosenberg E.S., Altfeld M., Poon S.H., Phillips M.N., Wilkes B.M., Eldridge R.L., et al. Immune control of HIV-1 after early treatment of acute infection. Nature 2000, 407:523-526.
9. Altfeld M., Rosenberg E.S., Shankarappa R., Mukherjee J.S., Hecht F.M., Eldridge R.L., et al. Cellular immune responses and viral diversity in individuals treated during acute and early HIV-1 infection. J Exp Med 2001, 193:169-180.
10. Betts M.R., Ambrozak D.R., Douek D.C., Bonhoeffer S., Brenchley J.M., Cassaza J.P., et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J Virol 2001, 75:11983-11991.
11. Pantaleo G., Demarest J.F., Soudeyns H., Graziosi C., Denis F., Adelsberger J.W., et al. Major expansion of CD8 T cells with a predominant V beta usage during the primary immune response to HIV. Nature 1994, 370:463-467.
12. Gorochov G., Neumann A.U., Kereveur A., Parizot C., Li T., Katlama C., et al. Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4 repertoire during antiviral therapy. Nat Med 1998, 4:215-221.
13. Gorochov G., Neumann A.U., Parizot C., Li T., Katlama C., Debré P., et al. Down-regulation of CD8 T-cell expansions in patients with human immunodeficiency virus infection receiving highly active combination therapy. Blood 2001, 97:1787-1795.
14. Lichterfeld M., Yu X.G., Mui S.K., Williams K.L., Trocha A., Brockman M.A., et al. Selective depletion of high-avidity human immunodeficiency virus type 1 (HIV-1)-specific CD8 T cells after early HIV-1 infection. J Virol 2007, 81:4199-4214.
15. Islam S.A., Hay C.M., Hartman K.E., He S., Shea A.K., Trocha A.K., et al. Persistence of human immunodeficiency virus type 1-specific cytotoxic T-lymphocyte clones in a subject with rapid disease progression. J Virol 2001, 75:4907-4911.
16. Soudeyns H., Campi G., Rizzardi G.P., Lenge C., Demarest J.F., Tambussi G., et al. Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality. Blood 2000, 95:1743-1751.
17. Giovannetti A., Pierdominici M., Mazzetta F., Salemi S., Marziali M., Kuonen D., et al. T cell responses to highly active antiretroviral therapy defined by chemokine receptors expression, cytokine production, T cell receptor repertoire and anti-HIV T-lymphocyte activity. Clin Exp Immunol 2001, 124:21-31.
18. Giovannetti A., Pierdominici M., Marziali M., Mazzetta F., Caprini E., Russo G., et al. Persistently biased T-cell receptor repertoires in HIV-1-infected combination antiretroviral therapy-treated patients despite sustained suppression of viral replication. J Acquir Immune Defic Syndr 2003, 34:140-154.
19. Yin L., Kou Z., Rodriguez C., Hou W., Goodenow M.M., Sleasman J.W., et al. Antiretroviral therapy restores diversity in the T cell receptor V repertoire of CD4 T cell subpopulations among human immunodeficiency virus type 1 infected children and adolescents. Clin Vaccine Immunol 2009, 16:1293-1301.
20. Yin L., Rodriguez C., Hou W., Potter O., Caplan M.J., Goodenow M.M., et al. Antiretroviral therapy corrects HIV-1-induced expansion of CD8+ CD45RA+ CD2-) CD11a (bright) activated T cells. J Allergy Clin Immunol 2008, 122:166-172.
21. Hebbeler A.M., Propp N., Cairo C., Li H., Cummings J.S., Jacobson L.P., et al. Failure to restore the Vγ2-Jγ1.2 repertoire in HIV-infected men receiving highly active antiretroviral therapy (HAART). Clin Immunol 2008, 128:349-357.
22. Vallejo A., Valladares A., De Felipe B., Vivancos J., Gutierrez S., Soriano-Sarabia N., et al. High thymic volume is associated with viral replication and immunologic impairment only early after HAART interruption in chronic HIV infection. Viral Immunol 2005, 18:740-746.
23. Yu X.G., Lichterfeld M., Chetty S., Williams K.L., Mui S.K., Miura T., et al. Mutually exclusive T-cell receptor induction and differential susceptibility to human immunodeficiency virus type 1 mutational escape associated with a two-amino-acid difference between HLA class I subtypes. J Virol 2007, 81:1619-1631.
24. Meyer-Olson D., Brady K.W., Bartman M.T., O'Sullivan K.M., Simons B.C., Conrad J.A., et al. et al Fluctuations of functionally distinct CD8+ T-cell clonotypes demonstrate flexibility of the HIV-specific TCR repertoire. Blood 2006, 107:2373-2383.
25. McCloskey T.W., Haridas V., Pahwa R., Pahwa S. T cell receptor V beta repertoire of the antigen specific CD8 T lymphocyte subset of HIV infected children. AIDS 2002, 16:1459-1465.
26. Romiti M.L., Cancrini C., Castelli-Gattinara G., Di Cesare S., Ciaffi P., Bernardi S., et al. Kinetics of the T-cell receptor CD4 and CD8 V beta repertoire in HIV-1 vertically infected infants early treated with HAART. AIDS 2001, 15:2075-2084.
27. Sriram U., Wong M., Caillier S.J., Hecht F.M., Elkins M.K., Levy J.A., et al. Quantitative longitudinal analysis of T cell receptor repertoire expression in HIV-infected patients on antiretroviral and interleukin-2 therapy. AIDS Res Hum Retroviruses 2007, 23:741-747.
28. Grant M., Pardoe I., Whaley M., Montaner J.S., Harrigan P.R. The T cell receptor V beta repertoire shows little change during treatment interruption-related viral rebound in chronic HIV infection. AIDS 2002, 16:287-290.
29. Guille M., Andrieu M., Braudeau C., Ruiz C., Daniel N., Pallier A., et al. Serial evolution of TCR beta chain transcript mobilization in HIV type-1-infected patients following vaccine immune stimulation and HAART interruption. AIDS Res Hum Retroviruses 2006, 22:648-656.
30. Yang O.O., Church J., Kitchen C.M., Kilpatrick R., Ali A., Geng Y., et al. Genetic and stochastic influences on the interaction of human immunodeficiency virus type 1 and cytotoxic T lymphocytes in identical twins. J Virol 2005, 79:15368-15375.
31. Giacoia-Gripp C.B., Neves I., Galhardo M.C., Morgado M.G. Flow cytometry evaluation of the T-cell receptor Vbeta repertoire among HIV-1 infected individuals before and after antiretroviral therapy. J Clin Immunol 2005, 25:116-126.
32. Yu X.G., Lichterfeld M., Williams K.L., Martinez-Picado J., Walker B.D. Random T-cell receptor recruitment in human immunodeficiency virus type 1 (HIV-1)-specific CD8+ T cells from genetically identical twins infected with the same HIV-1 strain. J Virol 2007, 81:12666-12669.
33. Borkowsky W., Chen S.H., Belitskaya-Levy I. Distribution and evolution of T-cell receptor Vbeta repertoire on peripheral blood lymphocytes of newborn infants of human immunodeficiency virus (HIV)-infected mothers: differential display on CD4 and CD8 T cells and effect of HIV infection. Clin Vaccine Immunol 2007, 14:1215-1222.
34. Daucher M., Price D.A., Brenchley J.M., Lamoreaux L., Metcalf J.A., Rehm C., et al. Virological Outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8 T cells. J Virol 2008, 82:4102-4114.
35. Trautmann L., Janbazian L., Chomont N., Said E.A., Gimmig S., Bessette B., et al. Upregulation of PD-1 expression on HIV-specific CD8 T cells leads to reversible immune dysfunction. Nat Med 2006, 12:1198-1202.
36. Marchetti G., Cozzi-Lepri A., Merlini E., Bellistrì G.M., Castagna A., Galli M., et al. Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. AIDS 2011, 25:1385-1394.
37. Bentwich Z. Bacterial translocation: a useful biomarker for immune activation and disease progression. AIDS 2011, 25:1439-1441.
38. Brenchley J.M., Price D.A., Schacker T.W., Asher T.E., Silvestri G., Rao S., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat Med 2006, 12:1365-1371.
39. Klatt N.R., Funderburg N.T., Brenchley J.M. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013, 21:6-13.
40. Petrovas C., Casazza J.P., Brenchley J.M., Price D.A., Gostick E., Adams W.C., et al. PD-1 is a regulator of virus-specific CD8 T cell survival in HIV infection. J Exp Med 2006, 203:2281-2292.
41. Zhang J.Y., Zhang Z., Wang X., Fu J.L., Yao J., Jiao Y., et al. PD-1 up-regulation is correlated with HIV-specific memory CD8+ T-cell exhaustion in typical progressors but not in long-term nonprogressors. Blood 2007, 109:4671-4678.
42. Grant P.M., Zolopa A.R. When to start ART in the setting of acute AIDS-related opportunistic infections: the time is now!. Curr HIV/AIDS Rep 2012, 9:251-258.